International alert as fake Ozempic leads to serious hospitalizations

A shortage of authentic Ozempic (pictured) has resulted in counterfeits hitting the market, which caused hypoglycemic shock and coma in Austrian patients

With an industry expected to be worth US$100 billion by 2030, an ongoing supply crisis, a time-consuming manufacturing process, a high price tag and no generic alternatives, it's no surprise the much-hyped class of injectable weight-loss drugs has become a prime target for counterfeit trade.

Continue Reading

Category: Medical, Science

Tags: , , ,

Comentarios

Entradas más populares de este blog

Paddock Paradise focuses on storage and comfort – for people and cats